CA1253501A - Azetidinyl sulfonic acid and analogs - Google Patents
Azetidinyl sulfonic acid and analogsInfo
- Publication number
- CA1253501A CA1253501A CA000438477A CA438477A CA1253501A CA 1253501 A CA1253501 A CA 1253501A CA 000438477 A CA000438477 A CA 000438477A CA 438477 A CA438477 A CA 438477A CA 1253501 A CA1253501 A CA 1253501A
- Authority
- CA
- Canada
- Prior art keywords
- alkyl
- substituted
- amino
- phenyl
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43317582A | 1982-10-06 | 1982-10-06 | |
| US433,175 | 1982-10-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1253501A true CA1253501A (en) | 1989-05-02 |
Family
ID=23719123
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000438477A Expired CA1253501A (en) | 1982-10-06 | 1983-10-06 | Azetidinyl sulfonic acid and analogs |
Country Status (27)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1985004876A1 (en) * | 1984-04-24 | 1985-11-07 | Takeda Chemical Industries, Ltd. | 2-azetidinone derivatives and process for their preparation |
| EP0135194A1 (en) * | 1983-09-16 | 1985-03-27 | Takeda Chemical Industries, Ltd. | Azetidinones and their production |
| US4581170A (en) * | 1984-08-03 | 1986-04-08 | E. R. Squibb & Sons, Inc. | N-hydroxyl protecting groups and process and intermediates for the preparation of 3-acylamino-1-hydroxy-2-azetidinones |
| DE3588039T2 (de) * | 1984-08-06 | 1995-11-16 | Fujisawa Pharmaceutical Co | Azetidinonderivate und Verfahren zu ihrer Herstellung. |
| UY34585A (es) | 2012-01-24 | 2013-09-02 | Aicuris Gmbh & Co Kg | Compuestos b-lactámicos sustituidos con amidina, su preparación y uso |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4337197A (en) * | 1980-10-31 | 1982-06-29 | E. R. Squibb & Sons, Inc. | O-sulfated β-lactam hydroxamic acids and intermediates |
-
1983
- 1983-09-19 NZ NZ205642A patent/NZ205642A/en unknown
- 1983-09-22 GR GR72513A patent/GR79704B/el unknown
- 1983-09-30 BE BE0/211621A patent/BE897883A/fr not_active IP Right Cessation
- 1983-10-03 FR FR838315712A patent/FR2534253B1/fr not_active Expired
- 1983-10-04 DK DK457983A patent/DK457983A/da not_active Application Discontinuation
- 1983-10-05 GB GB08326626A patent/GB2129428B/en not_active Expired
- 1983-10-05 DE DE19833336262 patent/DE3336262A1/de not_active Withdrawn
- 1983-10-05 SU SU833652346A patent/SU1318146A3/ru active
- 1983-10-05 NO NO833626A patent/NO833626L/no unknown
- 1983-10-05 NL NL8303410A patent/NL8303410A/nl not_active Application Discontinuation
- 1983-10-05 LU LU85033A patent/LU85033A1/fr unknown
- 1983-10-05 JP JP58187674A patent/JPS5988462A/ja active Pending
- 1983-10-06 SE SE8305509A patent/SE8305509L/xx not_active Application Discontinuation
- 1983-10-06 IL IL69917A patent/IL69917A/xx unknown
- 1983-10-06 CA CA000438477A patent/CA1253501A/en not_active Expired
- 1983-10-06 AU AU19939/83A patent/AU568312B2/en not_active Ceased
- 1983-10-06 IT IT23172/83A patent/IT1171722B/it active
- 1983-10-06 KR KR1019830004744A patent/KR900005132B1/ko not_active Expired
- 1983-10-06 DD DD83255479A patent/DD222016A5/de not_active IP Right Cessation
- 1983-10-06 ES ES526282A patent/ES526282A0/es active Granted
- 1983-10-06 IE IE2354/83A patent/IE56600B1/en not_active IP Right Cessation
- 1983-10-06 ZA ZA837491A patent/ZA837491B/xx unknown
- 1983-10-06 CH CH5452/83A patent/CH658858A5/fr not_active IP Right Cessation
- 1983-10-06 PT PT77458A patent/PT77458B/pt not_active IP Right Cessation
- 1983-10-06 HU HU833460A patent/HU190507B/hu not_active IP Right Cessation
- 1983-10-06 FI FI833631A patent/FI833631A7/fi not_active Application Discontinuation
-
1985
- 1985-07-22 PH PH32549A patent/PH24175A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0051381B1 (en) | O-sulfated beta-lactam hydroxamic acids | |
| EP0076758B1 (en) | 4-ether derivatives of 2-azetidinone-1-sulfonic acids | |
| US4670553A (en) | 2-oxo-1-(aminocarbonylaminosulfonyl-aminocarbonyl)azetidines | |
| EP0085291B1 (en) | 2-oxo-1-(aminocarbonylaminosulfonylaminocarbonyl)azetidines | |
| CA1253501A (en) | Azetidinyl sulfonic acid and analogs | |
| US4534896A (en) | 3-Acylamino-2-oxoazetidine-1-(β-oxopropionic acid) | |
| US4559335A (en) | 3-Acylamino-1-carboxymethyloxy (or thio) carbonyl-2-azetidinones | |
| EP0068466B1 (en) | 4-aryl or heteroaryl thio-2-oxo-1-azetidinesulfonic acid salts and process for their preparation | |
| CA1198433A (en) | (s)-[1-(carbonylaminosulfonyl)-2-oxo-3- azetidinyl]-carbamic acid | |
| CA1253502A (en) | 4-[[(amidomethyl)oxy]methyl]-2-oxo-1- azetidinesulfonic acid salts | |
| CA1323368C (en) | 2-oxo-1-[[(substituted sulfonyl)amino]-carbonyl] azetidines | |
| CA1244037A (en) | (2-oxo-1-azetidinyloxy)-2-propenoic acid | |
| CA1254218A (en) | 4-(3-acylamino-2-oxo-1-azetidinyl)-4-oxo-2-butenoic acid | |
| US4551276A (en) | 2-Oxoazetidin-1-yloxymethyl sulfonic acid and analogs | |
| GB2207132A (en) | 2-oxo-1-(((substituted sulfonyl)amino)-carbonyl)azetidines | |
| US4647660A (en) | 3-acylamino-2-oxo-1-azetidinesulfonic acids | |
| EP0124123B1 (en) | 3-acylamino-1-sulfonylaminocarbonylmethoxy-2-azetidinones | |
| CA1268763A (en) | 3-acylamino-2-oxo-1-azetidinyl esters of phosphonic acids, phosphoric acid and phosphoric acid esters | |
| US4681937A (en) | 3-acylamino-2-oxo-1-azetidinyl esters of phosphonic acids, phosphoric acid and phosphoric acid esters | |
| CA1243679A (en) | 3-ACYLAMINO-2-OXO-1-AZETIDINYL-.beta.-OXYPROPIONATES | |
| GB2103212A (en) | 4-Substituted derivatives of 2-oxo-1-azatidinesulfonic acid salts | |
| CA1323029C (en) | 2-oxo-1-[(substituted sulfonyl)amino]carbonyl]azetidines | |
| US4889930A (en) | Process for making 2-oxo-1-((substituted sulfonyl)amino)carbonzyl)azetidines and intermediates used therein | |
| EP0135814A1 (en) | 1-(1H-tetrazol-5-ylalkoxy)-2-azetidinones | |
| US5106977A (en) | Intermediates for a process for making 2-oxo-1-[[(substituted sulfonyl)-amino]carbonyl]azetidines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry | ||
| MKEX | Expiry |
Effective date: 20060502 |